Partner

Andrew Finkelstein

New York, NY

Licensed in 3 States

About Andrew

Mr. Finkelstein’s career reflects a rare blend of legal excellence, educational leadership, and unwavering dedication to justice and public safety. Andrew Finkelstein is the Managing Partner of Finkelstein & Partners, LLP, where he has built a distinguished career advocating for injured individuals and holding corporate wrongdoers accountable. A nationally recognized consumer advocate and accomplished trial attorney, Mr. Finkelstein has successfully litigated numerous wrongful death and catastrophic injury cases, securing multiple multi-million dollar verdicts and settlements. Notably, he achieved a record $50 million confidential settlement for a single injury claim, $31 million jury verdict in Ulster County, NY, and a $13.5 million settlement in a motor vehicle accident case, as well as dozens of other multi-million dollar results. Mr. Finkelstein’s leadership extends beyond the courtroom. He currently serves as the 58th President of the New York State Trial Lawyers Association (NYSTLA) and is a dedicated faculty member and Executive Chairman at Trial School, a nationwide nonprofit organization committed to training trial lawyers. He is an accomplished author whose book, I Hope We Never Meet, reached #1 on New York Times best seller list. He has also taught at Keenan Trial Institute, Trial Lawyers University, and lectured at prestigious institutions including Harvard Law School and Brooklyn Law School. His continuing legal education (CLE) presentations span multiple state trial lawyer associations, including Massachusetts, New Hampshire, New York, Ohio, and Maryland, as well as national conferences such as Mass Torts Made Perfect, and National Trial Lawyer Academy. A passionate educator, Mr. Finkelstein frequently lectures at the Finkelstein & Partners Center for Continuing Legal Education. His topics include: Building the Case Using Experts and Lay Witnesses, Science in the Courtroom, Technology in the Courtroom, Prosecution of a Pharmaceutical Case, The Ethics of Online Advertising, Structured Settlements and Personal Injury Settlements. Mr. Finkelstein is also deeply committed to community service. He led the firm’s pro bono efforts as Captain of the 9/11 Victim Compensation Fund through “Trial Lawyers Care,” securing over $10 million for victims while waiving all legal fees. His leadership in this initiative earned him recognition from the Association of Trial Lawyers of America. In the realm of pharmaceutical litigation, Mr. Finkelstein has played a pivotal role in national cases involving dangerous drugs. He chairs the Plaintiff Personal Injury Steering Committee for the Neurontin Multi-District Litigation (MDL) in Boston and has worked closely with the FDA, filing a Citizen Petition to enhance suicide risk warnings. He also serves on the Executive Steering Committee for the Hormone Replacement Therapy MDL and is a key member of the Plaintiff Steering Committees for the Ortho Evra Birth Control Patch and Viagra MDLs. For 11 consecutive years (2014-2025) Mr. Finkelstein has been voted one of the nation’s top 50 most influential civil plaintiff’s trial lawyers by National Trial Lawyers, as published by The Trial Lawyer Magazine.